BRIEF published on 06/11/2026 at 15:31, 3 months 5 days ago Elis Reports Share Capital and Voting Rights as of May 31, 2026 Shareholders Voting Rights Shares Capital Structure Elis
BRIEF published on 06/11/2026 at 15:31, 3 months 5 days ago Elis: Declaration of Shares and Voting Rights as of May 31, 2026 Share Capital Voting Rights Actions Transparency Elis
PRESS RELEASE published on 06/11/2026 at 15:26, 3 months 5 days ago Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 05 2026 Elis SA discloses the number of shares forming the capital and voting rights as of 31 May 2026. Detailed information available on www.elis.com Voting Rights Shares Financial Statement Disclosure Elis SA
BRIEF published on 06/11/2026 at 07:05, 3 months 6 days ago Elis joins the UN Global Compact Board Board Of Directors Global Compact CSR UN Elis
BRIEF published on 06/11/2026 at 07:05, 3 months 6 days ago Elis Joins UN Global Compact Board in France UN Global Compact CSR Strategy Elis Sustainable Economy Circular Services
PRESS RELEASE published on 06/11/2026 at 07:00, 3 months 6 days ago Elis joins the Board of the UN Global Compact – Network France Elis joins the Board of the UN Global Compact - Network France, strengthening commitment to CSR and sustainable economy. Xavier Martiré comments on the appointment UN Global Compact CSR Elis Sustainable Economy Xavier Martiré
BRIEF published on 06/09/2026 at 07:05, 3 months 8 days ago Elis Expands in Spain with Acquisition of RS10 Acquisition Healthcare Sector Spain Elis RS10
PRESS RELEASE published on 06/09/2026 at 07:00, 3 months 8 days ago Elis announces the acquisition of RS10 in Spain Elis acquires RS10 in Spain, enhancing local presence in healthcare sector and industrial capacity. RS10 adds €5.5 million revenue in 2025 Acquisition Revenue Spain Elis RS10
BRIEF published on 05/27/2026 at 12:16, 3 months 20 days ago Elis: Update on the conversion ratio of the 2029 OCEANE bonds Convertible Bonds Dividend Elis OCEANE 2029 Conversion Ratio
PRESS RELEASE published on 05/27/2026 at 12:11, 3 months 20 days ago Elis: Adjustment to the conversion ratio (OCEANE 2029) Elis adjusts the conversion/exchange ratio for OCEANE 2029 bonds following the distribution of €0.48 per share. Shareholders' meeting approved the distribution on May 21, 2026 Shareholders Meeting Elis OCEANE 2029 Conversion Ratio Adjustment
Published on 09/16/2026 at 23:45, 7 hours 45 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 16:55, 14 hours 35 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 16 hours 30 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 17 hours 30 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 07:15, 15 minutes ago Infracore ergänzt ihr Angebot für die Immobilien des Spitals Wetzikon und verlängert dessen Gültigkeit bis zum 31. Oktober 2026
Published on 09/17/2026 at 07:00, 29 minutes ago Helvetia Baloise delivers strong half-year operating results and fast integration progress while maintaining excellent capitalisation
Published on 09/17/2026 at 07:00, 30 minutes ago MCH Group continues its progress with a strong first half year result, further strengthening profitability
Published on 09/17/2026 at 07:00, 30 minutes ago AEVIS VICTORIA SA: Publication of the Half-Year Report 2026 – Significant improvement in Swiss Medical Network’s profitability – Hospitality segment records encouraging results
Published on 09/17/2026 at 07:00, 30 minutes ago MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
Published on 09/16/2026 at 17:45, 13 hours 45 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 13 hours ago Report on the Combined General Meeting of the 10th of September 2026
